[ET Net News Agency, 6 July 2020] Sino Biopharmaceutical Limited (01177) said "Invert
Sugar Injection" (brand name: Fenghaixin), a body fluid and energy supplement developed by
the group, has obtained approval for drug registration granted by the National Medical
Products Administration of the People's Republic of China.
The product is available in 5% (250ml: glucose 6.25g and fructose 6.25g) and 10% (250ml:
glucose 12.5g and fructose 12.5g) specifications. It can be directly infused clinically to
replenish body fluid and energy, especially with patients with diabetes and patients with
insulin resistance such as burn trauma and postoperative, and can also be used for the
treatment of drug poisoning and alcoholism. (RC)